Channel Therapeutics Corp...

NYSE: PTHS · Real-Time Price · USD
22.73
0.14 (0.62%)
At close: Aug 26, 2025, 1:16 PM
22.60
-0.59%
After-hours: Aug 26, 2025, 04:08 PM EDT

Channel Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024
Net Income
-3.45M -1.97M -1.93M -1.69M -1.77M -2.56M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
413.49K 485.83K 530.42K 517.34K 458.98K 292.55K
Other Working Capital
27.63K 48.96K 28.98K -686.51K -67.67K -372.95K
Other Non-Cash Items
164.68K 94.21K 76.09K -352.79K n/a 605.63K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
2.42M 755.44K 649.96K 1.35M -1.64M -327.75K
Operating Cash Flow
-447.14K -632.13K -670.26K -177.91K -2.95M -1.99M
Capital Expenditures
n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a n/a
Debt Repayment
375K 250K -153.82K -897.28K 1.59M -214.76K
Common Stock Repurchased
n/a n/a n/a -75K n/a -91.51K
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a
Financial Cash Flow
375K 250K -71.2K -972.28K 1.59M 5.67M
Net Cash Flow
-72.14K -382.13K -741.46K -1.15M -1.37M 3.67M
Free Cash Flow
-447.14K -632.13K -670.26K -177.91K -2.95M -1.99M